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Introduction. Constipation is a common, bothersome, and potentially dangerous condition among nursing home (NH) patients.
Between 50 and 74% of NH patients use laxatives. Objective. To study prevalence and associations of laxative use and constipation
using the comprehensiveNorwegian version of the Resident Assessment Instrument for Long-TermCare Facilities.Methods.Cross-
sectional study. Patients from 20 NH units were included. Logistic regression was used to analyze the results. Data collected in NHs
might be clustered. Consequently, the multivariable models were tested against a mixed effects regression model to investigate
variance both on the level of patients and on the level of NH units. Results. In all, 261 patients were included. The prevalence
of constipation was 23.4%, and 67.1% used laxatives regularly. Balance problems, urinary incontinence, hypothyroidism, and
Parkinson’s disease were associated with constipation. Reduced ability to communicate and number of drugs were associated with
laxative use. Antidementia-drugs and being involved in activities 1/3 to 2/3 of daytime were protective factors for laxative use.
Mixed effects analyses identified variance on the level of NH units as nonsignificant. Conclusion. Constipation and laxative use are
common. Variance is mainly explained by different patient characteristics/health deficiencies. Hence, patients might benefit from
individualized care to compensate for deficiencies.
1. Introduction
The management of constipation among patients in nursing
homes (NHs) is challenging for both patients and health care
staff [1]. Constipation is not a well-defined disease, but a
general term describing the difficulties a person experiences
with their bowelmovements [2]; thus epidemiological studies
show great disparity in the reporting of prevalence. The
prevalence of constipation increases with age, with the largest
increase in prevalence after the age of 70 years [3, 4]. Women
are 2-3 times more likely to have constipation than men
[3, 4]. Between 17 and 40% of the community-dwelling older
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adults [5–7] and between 10 and 72% [8–11] of NH patients
experience constipation.
Constipation can be classified as primary (idiopathic or
functional) or secondary (iatrogenic or because of organic
disease), the latter being more common in older people
[12]. Diseases associated with constipation are endocrine or
metabolic disorders; gastrointestinal disorders; neurological
disorders; and psychological comorbidities [4]. Other con-
tributory factors to the higher prevalence of constipation
among older people include poor dietary fibre, fluid and calo-
rie intake, immobility, weak abdominal and pelvic muscles,
and cognitive impairment and medication side effects [12].
Among NH patients constipation is associated with impaired
health-related quality of life [13–16], physical aggression
[17], and psychological distress [16]. Chronic constipation
can lead to faecal impaction [4, 6], and in severe cases,
faecal impaction can cause stercolar ulcerations, intestinal
obstruction, or bowel perforation [1]. Other complications
of constipation are related to excessive straining that can
contribute to haemorrhoids, anal fissures and rectal prolapse.
Excessive straining can affect the cerebral and coronary
circulation with resultant syncope or cardiac ischemia [12].
Some age-related changes in anorectal physiology have been
described [2]. However, constipation should not be regarded
as a physiological consequence of normal aging, since most
healthy older people have normal bowel function [2]. Nurses
working in NHs report constipation as hard to manage due
to busy working days with many tasks, so that good bowel
routines have low priority [18]. Further, staff discontinuity
and a high proportion of unskilled nursing aides among
the staff hinder good management of the patients’ bowels
[18, 19].
In addition to conservative interventions such as dietary
fibre, physical activity, and fluids, laxatives are the corner-
stone in the treatment of constipation. Between 50 and 74%of
NH patients are reported to use laxatives regularly [4, 8]. All
groups of laxatives are superior to placebo [20]. However, in
contrast to the overall good results in clinical trials, patients’
satisfaction with everyday use of laxatives is rather low [21].
Laxatives may serve as a marker for constipation because
they are rarely used for other indications. Indeed, several NH
studies have used laxatives as a proxymarker for constipation
[8, 22–24]. In addition, constipation is a significant driver of
health care costs including laxative use and time resources for
health care personnel dealing with the problem in hospitals
and NHs [25, 26]. In Norway, with a population of approx-
imately 5.2 million, 18.9 million C was spent on laxatives
in 2014 [27]. Constipation is a multifactorial condition with
huge variability in reported prevalence in theNHpopulation.
There is therefore a need to investigate the condition with
validated instruments. The Resident Assessment Instrument
for Long-Term Care Facilities (interRAI LTCF) [28] is a
standardized, validated and comprehensive tool to assess
patients’ health condition in the long-term care setting, which
allow for international comparability. In addition, it is poorly
understoodwhether clustering of observations inNHs affects
the results [29, 30], and whether variability in prevalence
found is due to differences between patients or differences
between NH units [31].
The aim of this study was to study prevalence and asso-
ciations of constipation and laxative use among NH patients
using the Norwegian version of the interRAI LTCF [28]. A
secondary aim was to investigate the effect of clustering of
observations and whether living in different NH units had an
impact on the prevalence of constipation and laxative use by
analysing data using mixed effects models.
2. Materials and Methods
2.1. Design. A cross-sectional design was employed. The
study was performed in NHs in one urban municipality in
Norway, during September and October 2014. Data were
collected at baseline in an ongoing cluster-randomized con-
trolled trial investigating the effect of an educational program
for care staff about faecal incontinence in NH patients [32].
Sample-size calculations for the trial are reported elsewhere
[32]. The trial is registered in the clinical trial registry
(NCT02183740).
2.2. Setting. Most Norwegian NHs are owned and run by the
municipalities, are oftentimes managed by Registered Nurses
(RNs), and have an agreement with a general practitioner
(GP) who visits the NH once a week. There are no legal
requirements for staff-to-patient ratios or specifications for
qualifications required for care workers [33]. However, NHs
have RNs on duty 24 hours a day, and according to Statis-
tics Norway the staff comprises on average 31% RNs, 45%
licenced practical nurses who are care staff with high school
education, and 24% healthcare aides with no formal health
care education [34]. In Norway, a majority of NH patients are
above 67 years and have complex health problems, significant
deficiencies in functioning related to activities of daily living
(ADL), and about 80% have cognitive impairment [35].
2.3. Patients. Patients were recruited fromNHs.Out of a total
of 27 NHs available in the municipality, 20 NH units from 10
different NHs were recruited. All NHs had 24 hour long-term
residency, comparable staff-to-patient ratios on the day shift
and similar GP coverage. Specialized NH units or units with
enhanced staff-to-patient ratios were excluded. All long-term
care patients with a stay of four weeks or more were eligible
for inclusion.
2.4. Variables. The interRAI LTCF is a standardized, val-
idated, and comprehensive tool to assess patients’ health
status in the long-term care setting [28, 36–38]. In this study
interRAI LTCF sections C to O were included, and the
following variables were used.
Constipation was measured by interRAI LTCF, section
J: Constipation, defined as no bowel movements for three
days or problems with hard stools. Based on this definition,
the RNs coded 0 for not constipated, 1 for problems with
constipation, but no symptoms the last three days, 2 for
symptoms of constipation present 1 of the last 3 days, 3 for
symptoms of constipation present for 2 of the last 3 days, and
4 for symptoms of constipation present daily for the last 3
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days. For this study, all patients with the scores 1 to 4 were
defined as constipated.
Laxative use prescribed as regularly used in the patient
record and recorded in interRAI, sectionN:Medications, and
grouped according to the Anatomical-Therapeutic-Chemical
Classification System (ATC) [39] (see (xi) below).
Informed by other studies [4, 6] the following variables
from interRAI were used to investigate possible associations:
(i) Patients’ cognitive status was measured by the Cogni-
tive Performance Scale (CPS) [40]. Scores range from
0 to 6, where 0 represents being cognitively intact.
To define presence of cognitive impairment, the usual
cutoff of 2 points or more was used [41].
(ii) Patients’ functional status wasmeasured by the Activ-
ities of Daily Living long form scale (ADLlf) [42].The
items in this study differ from the original scale due
to differences in ADL items in the Norwegian version
of the interRAI LTCF. After communicating with a
Norwegianmember of the interRAI organization, the
following 7 items were included: personal hygiene,
dressing upper body, dressing lower body, locomo-
tion, toilet use, eating, and bed mobility. Scores
range from 0 to 28, where 0 indicates no functional
difficulty.
(iii) The Depression Rating Scale (DRS) [43] was used to
measure depression symptoms. Scores range from 0
to 14, where 0 indicates no depression symptoms.
(iv) Patients’ instability in health/frailty was measured by
the Changes in Health, End-Stage Disease, Signs, and
Symptoms Scale (CHESS) [44]. Scores range from 0
to 5, where 0 indicates stability in health.
(v) TheAggressive Behavior Scale (ABS) [45] was used to
measure aggressive behavior. Scores range from 0 to
12, where 0 indicates no aggressive behavior.
(vi) The Revised Index for Social Engagement (RISE)
was used to measure the degree of involvement in
positive social activities [46]. Scores range from 0
to 6, where 0 indicates no involvement in positive
activities. Compared to the other scales derived from
interRAI LTCF, this is the only scale where low score
is worst rather than best.
(vii) The communication scale (COMM) was constructed
by summing the scores for the variables “expressive
communication skills” and “receptive communica-
tion skills,” each with a score range of 0 to 4. This
resulted in a score range for COMM from 0 to 8,
where 0 indicates no communication problems [47].
(viii) Four variables measuring Balance in section J3 were
used to construct a scale to measure balance: the four
variableswere: “Has difficulties or is unable tomove to
the standing position without help”, “Has difficulties
or is unable to turn to the opposite direction when
standing”, “Dizziness”, and “Walking instability”.
The individual variables were dichotomized and the
scores then summed giving a score range from 0 to 4,
where 0 indicates no balance problems.
(ix) The following individual interRAI LTCF variables
were used: “Faecal incontinence”, “Urinary inconti-
nence”, “Pressure ulcers”, “Maximum walking dis-
tance”, “Locomotion”, “Activity level”, “Fatigue”,
“Body mass index”, “ Dehydration”, Type of food
(Regular or soft/liquid diet).
(x) The patients’ medical condition was measured by
section I of interRAI LTCF: “Alzheimer’s disease”,
“Dementia other than Alzheimer’s disease”, “Hemi-
plegia”, “Multiple sclerosis”, “Paraplegia”, “Parkin-
son’s disease”, “Quadriplegia”, “Cerebrovascular acci-
dent (stroke)”, “Cardiovascular disease”, “Conges-
tive heart failure”, “Chronic obstructive lung dis-
ease”, “Anxiety disorder”, “Bipolar disease”, “Depres-
sion”, “Schizophrenia”, “Pneumonia”, “Urinary tract
infection”, “Cancer”, “Diabetes mellitus”, “Hypothy-
roidism”. Comorbidity is measured by summing the
above diagnoses giving one point per diagnosis.
(xi) Medications were measured by section N of interRAI
LTCF and grouped according to the ATC-System,
primarily on level four since drugs at this level
often have common adverse drug reactions [48]:
“opiates (N02A)”, “antiepileptics (N03A)”, “antipsy-
chotics (N05A)”, “anxiolytics (N05A)”, “hypnotics
and sedatives (N05C)”, “diuretics (C03)”, “antide-
pressants (N06A)”, “anti-dementia drugs (N06D)”
“iron supplements (B03A)”, “calcium supplements
(A12A)” “antidiarrheal agents (A07D)” and “laxatives
(A06A)”. Groups of laxatives were defined at ATC-
level 5: softening laxatives (A06A A), stimulant lax-
atives (A06A B), bulk laxatives (A06A C), osmotic
laxatives (A06A D), and enemas (A06A G).
In addition, the questionnaire included a section where
RNs were offered a list of interventions relevant for constipa-
tion and asked to identify what is done for each individual
patient. This list included questions about administration of
laxatives (tablets, oral liquid, and suppositories) and enemas.
2.5. Data Collection. The project coordinator and a research
assistant gave information and training to RNs (2-3 hours
per NH) on completion of all the measures listed above. RNs
were trained to use the interRAI LTCF standardized coding
guidelines provided in the instrument’s trainingmanual. RNs
used clinical judgment together with information from the
electronic patient record, coworkers, and the patients when
filling in the questionnaire.
2.6. Statistics. Statistical methods included estimating preva-
lence in percentages and other descriptive statistics. InterRAI
LTCF offers a large number of variables. Univariable logistic
regression analysis was conducted on the variables identified
under data collection.We used perceived clinical significance,
log likelihood, McFadden’s 𝑅2, and 𝑝 ≤ 0.05 to assess degree
of impact on the outcome variable to inform the choice of
variables to include in the multivariable logistic regression
model [49]. To ensure sufficient events per independent
variable in the multivariable models, the ratio was set at
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a maximum of 10 : 1 [49–51]. Effect sizes are presented as
odds ratios (OR) with 95% CI and 𝑝 values. Variables were
considered significant if 𝑝 < 0.05, but 𝑝 values between
0.01 and 0.05 were interpreted with caution due to multiple
comparisons. The McKelvey and Zavoina 𝑅2 was used to
examine explained variability in the multivariable models.
Its calculations are based on predicting a continuous latent
variable underlying the observed 0-1 outcomes of data but
need to be interpreted with caution compared to the adjusted
𝑅
2 in the Ordinary Least Squares regression [52, 53].
2.7. Tests of Statistical Assumption. Basic assumptions for
logistic regression must be tested and reported [29, 49, 54].
One assumption is linearity in the logit for any continuous
independent variables [49, 51]. For this we performed a link-
test [55, 56].The independent variables were also investigated
formulticollinearity bymeans of the tolerance value that indi-
cates the variables’ uniqueness in explaining variation, where
zero means perfect collinearity between variables. Perfect
collinearity makes it impossible to obtain a unique estimate
of regression coefficients for the involved variables [49, 56].
A definite cut-off criteria for “too much” multicollinearity
do not exist. However, it is suggested that a value below
0.1 is problematic [57]. Assessments of the overall model fit
were conducted by using the Hosmer-Lemeshow test [49,
51, 58]. Another assumption is independence between the
observations. Patient observations collected in NHs might
be described as clustered data and thereby correlated [59].
Consequently, the multivariable logistic regression models
were tested against a mixed effects logistic regression model
with the NH units treated as a random effect to investigate
whether this further improved the model. STATA and the
xtlogit command provide a likelihood-ratio test for the null
hypotheses that the NH unit-level variance is significantly
different from zero. In addition, the mixed effects logistic
regression model makes it possible to investigate variance on
two levels, the level of the individual patient versus the level of
the NHunit [29, 60].TheAkaike information criterion (AIC)
and the Bayesian information criterion (BIC) were used to
comparemodel fit of themultivariablemodels and themixed-
effect models [30].
No replacements were made for missing data; thus, the
number of patients varies between the different analyses.
Statistical analyses were performed using STATA version 13
(StataCorp LP, Texas, USA).
2.8. Ethical Considerations. The study was approved by the
Regional Committee for Medical and Health Research Ethics
(REK) (2013/1802/REK North) and byThe Norwegian Social
Science Data Services (36482/2/MB). An essential ethical
consideration in this study was whether or not informed
consent should be obtained from patients or their represen-
tatives. After evaluating the overall project, REK authorized
RNs with dispensations from the duty of confidentiality to
gather relevant patient health information (proxy data). Since
dispensation was given, patient consent was not obtained.
The study was performed in accordance with the Helsinki
Declaration.
Table 1: Patients characteristics1, 𝑛 = 261.
Age, years 84.7 (8.3)
Gender, female 173 (66.3)
CPS2 ≥ 2 177 (69)
BMI2 23.1 (5.1)
ADL2 long form 12.6 (9.3)
Locomotion
(i) Walks without aid 52 (20.0)
(ii) Walks with aid (e.g., cane, crutches, rollator) 140 (53.8)
(iii) Wheelchair 56 (21.5)
(iv) Bed-ridden 12 (4.6)
Length of stay, years 2.3 (2.5)
Number of medical diagnoses 2.6 (1.5)
Number of drugs 7.0 (3.5)
1The results are given as mean (standard deviation (SD)) and number
(proportion (%)).
2CPS = Cognitive Performance Scale, BMI = body mass index, ADL =
activities of daily living.
3. Results
3.1. Characteristics of the Patients. The study included all
patients (𝑛 = 261) within eligibility criteria from20NHunits.
Patient characteristics are presented in Table 1.
3.2. Constipation. Therewere 61 (23.4%) patients with consti-
pation. Table 2 shows the result from the univariable logistic
regression analyses. Because of the 10 : 1 ratio criteria, only
six of the variables were included in the multivariable model.
The variables with the highest impact (log likelihood and
McFadden’s 𝑅2) on the dependent variable in the univariable
analyses and/or variables considered as clinical significant
were included in the multivariable logistic regression model
(Table 2).
3.2.1. Mixed Effect Logistic Regression: The Constipation
Model. The results are presented in Table 2. The likelihood-
ratio statistic for the constipation model was 1.97 giving
𝑝 = 0.08. Thus, the variance between NH units did not
have a significant influence on the results, and thereby a
multilevelmodelwas not required.The analyses resulted in an
intracluster correlation coefficient (ICC) = 0.097, indicating
90.3% of the variance in the data being on the individual
patient level.The analyses comparing the multivariable logis-
ticmodel with themixed effect logisticmodel resulted in AIC
and BIC values for the logisticmodel of 198.47 and 222.29 and
for the mixed model 198.50 and 225.72, respectively. Lower
AIC and BIC values indicate the better fit. This means that
the result indicates a slightly better fit for the multivariable
logistic regression model compared to the mixed effects
model [30]. Hence, below we will present adjusted ORs from
the multivariable logistic regression model (Table 2).
3.2.2. Adjusted Results. The results show that the odds of con-
stipation increase with anOR of 1.69 for each unit increase on
the Balance scale, andOR of 1.34 for each unit increase on the
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Table 3: Use of laxatives among patients, 𝑛 = 261.
Laxative type
Patients using
laxatives, 𝑛
(%)
Use of laxatives as prescribed in the patients
record
Laxatives regularly1 and on demand1 187 (71.7)
Laxatives regularly only 175 (67.1)
(i) Stimulant laxative (A06A B)2 87 (33.3)
(ii) Osmotic laxatives (A06A D) 143 (54.8)
(iii) Softening laxatives (A06A A) 1 (0.4)
(iv) Microenema (A06AG02 or A06AG11) 4 (1.5)
(v) Bulk laxatives (A06A C) 0 (0)
(vi) Oil enema (A06AG04) 0 (0)
(vii) Minienema (A06AG10) 0 (0)
Use of enemas as reported by nurses
(i) Microenema (A06AG02 or A06AG11) 78 (30.0)
(ii) Oil enema (A06AG04) 10 (3.9)
(iii) Minienema (A06AG10) 6 (2.3)
Number of laxatives per patient3
0 76 (29.1)
1 88 (33.7)
2 58 (22.2)
3 35 (13.4)
4 4 (1.5)
1Regular use and on demand as prescribed in the patient record.
2Laxatives are grouped according to the Anatomical-Therapeutic-Chemical
Classification System (ATC).
3Reported as regular use in the patient record together with the use of
microenemas, oil enemas, and minienemas as reported by nurses.
urinary incontinence scale. Patientswhowere diagnosedwith
hypothyroidism had a higher risk of constipation (OR 8.59)
compared with patients not diagnosed with hypothyroidism.
Being diagnosed with Parkinson’s disease resulted in an OR
of 7.03 compared to patients not diagnosed with Parkinson’s
disease.This finalmodel resulted in aMcKelvey andZavoina’s
𝑅
2 of 0.312. This means that 31.2% of the total variability of
constipation among patients can be explained by the variables
in the model.
3.3. Use of Laxatives. The use of laxatives is reported in
Table 3. There were 175 (67.1%) patients using laxatives
regularly as reported on the drug charts. Forty-six (75.4%)
of the patients defined by the nurses as constipated used
laxatives regularly. As shown in Table 3, we found a rather
huge difference in the use of enemas as prescribed in the
patient record compared to the use of enemas as reported by
RNs. Table 4 shows the result from the univariable logistic
regression analyses. Again, the variables with the highest
impact (log likelihood and McFadden’s 𝑅2) on the depen-
dent variable in the univariable analyses and/or variables
considered as clinically significant were included in the
multivariable logistic regression model (Table 4).
3.3.1.Mixed Effect Logistic Regression:The LaxativeUseModel.
The results are presented in Table 4. The likelihood-ratio
statistic was 0.21 giving 𝑝 = 0.325, indicating also here that
the variance between NH units did not have a significant
influence on the results, and thereby a multilevel model
was not required. The analyses resulted in an ICC = 0.031,
indicating 96.9% of the variance in the data being on the
individual patient level. The analyses comparing the multi-
variable logistic model with the mixed effects logistic model
resulted inAIC andBICvalues for the logisticmodel of 292.62
and 356.15 and for the mixed model of 294.41 and 361.47,
indicating best fit for the multivariable logistic regression
model [30]. Hence, we will also here present adjusted ORs
from the multivariable logistic regression model (Table 4).
3.3.2. Adjusted Results. The results shows that OR for laxative
use increases by 1.22 for each unit increase on the COMM
scale, and with an OR of 1.23 for each increase in number of
medications other than laxatives. Being engaged in activities
between 1/3 and 2/3 of daytime resulted in a protective effect
(OR=0.28) compared to the patients not engaged in activities
at all. Taking antidementia medications gave a protective
effect with an OR = 0.17 compared to patients not taking
antidementia medications. This final model resulted in a
McKelvey and Zavoina’s 𝑅2 of 0.369, explaining 36.9% of the
total variability.
3.4. Results of the Test for Statistical Assumptions
Linearity in the Logit. For both regressionmodels, the linktest
was not significant with𝑝 = 0.802 for the constipationmodel,
and 𝑝 = 0.245 for the laxative use model. This means that
the model was properly specified and that the assumption of
linearity was fulfilled [55, 56].
Multicollinearity. For the model with “constipation” as the
dependent variable no adjustment of the model was made
as a result of the tolerance test. The variable with the lowest
value was “CHESS” with the value 0.89. For the model
with “Laxative use” as the dependent variable, ADLlf had a
tolerance value of 0.27, which is rather low but not surprising
since ADLlf includes a range of measures that might interfere
with the uniqueness of the variable in the multivariable
analyses. However, after investigating the fit of different
alternatives with and without ADLlf, and the variables “Type
of food”, “Maximum walking distance”, and “Locomotion”,
we chose to keep ADLlf in themodel and exclude “Maximum
walking distance”. This maneuver changed the tolerance
value for ADLlf from 0.27 to 0.33. Either way, the models
were stable considering 𝑝 values and confidence intervals
in the different alternatives. The result from the Hosmer-
Lemeshow test on the final models resulted in a goodness-
of-fit 𝜒2 = 5.38, 𝑝 = 0.716, for the constipation model
and goodness-of-fit 𝜒2 = 6.11, 𝑝 = 0.635, for the laxative
use model. This means that both models fit the data well
[58].
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4. Discussion
4.1. Constipation. The prevalence of constipation was 23.4%
among NH patients. Comparison of prevalence rates in gen-
eral is difficult because the definitions of constipation vary.
In the NH population, there is even larger variation amongst
estimates of constipation, from 10% [11] up to 72% [6, 8].
In this study, there was no significant association between
either age or gender and constipation among NH patients.
This is different compared to the general population where
constipation is more prevalent among women and where age
is considered a risk factor [3, 4]. Since two reviews have
identified the age of 65–70 years as when there is a particular
increase in prevalence [4, 12], this study investigated age both
as a continuous variable and as a categorical variable grouping
patients on the bases of age with emphasis on age groups
identified in the above-mentioned reviews. Either way, age
was not significantly associated with constipation.Thismight
mean that when living in a NH, factors other than age and
gender are of importance.
Hypothyroidism and Parkinson’s disease were signifi-
cantly associated with constipation. This is consistent with
findings in two reviews [4, 6].These publications additionally
identified stroke/cerebrovascular disease as a risk factor for
constipation, which was not in this study. This might be
explained by the rather small subgroup with these conditions
and thereby a lack of power to explain associations between
constipation and stroke. The same reviews [4, 6] identified
reduced mobility and functional decline as risk factors for
constipation. In our study, ADL lost its significance in the
multivariable analyses. The rest of the variables available
in interRAI LTCF measuring function and mobility were
not significant in the univariable analyses or had too little
impact on constipation to be considered for themultivariable
analyses. On the other hand, the condition with the strongest
impact on constipation was “balance.” Together, these find-
ings suggest that balance problems are of greater importance
than ADL deficiencies and immobility in the understanding
of constipation.
Type of food (regular, soft/liquid), body mass index
(BMI), and dehydration also had too little impact to be
considered for themultivariable analyses. It is often suggested
that insufficient diet, hydration, fiber, and physical activity
are associated with constipation, but the evidence behind
these factors is inconsistent and of low to medium quality
[4, 6]. If this is the case, our results confirm these factors
having a weak impact on constipation. However, Leung et
al. [4] conclude that increasing fiber, exercise, and fluids
might benefit patients with actual deficiencies. Our study
also identified urinary incontinence as a risk factor for
constipation. The association between urinary incontinence
and constipation can be linked to common muscular and
neurological processes regulating continence, defecation, and
urinating. It might also be a result of an adverse effect from
drugs used for urinary incontinence.
4.2. Use of Laxatives. In this study 67.1% of the patients
used laxatives regularly. Other studies have reported regular
use of laxatives in NHs from 55.3% to 83.6% [7, 24, 31,
61, 62]. Only number of drugs and ability to communicate
remained significant risk factors in the adjusted analyses.The
number of drugs as a risk factor for laxative use is found in
several other studies [7, 24, 31]. Opiates were the only drug
significantly associated with laxative use in the univariable
analyses but lost significance in the adjusted analyses. These
findings are opposite to the findings by Fosnes et al. [8] among
NH patients in another part of Norway. They did not find a
significant association between number of drugs and laxative
use but found some antidepressants and benzodiazepine
derivates as independent predictors. vanDijk et al. [22] found
the overall adverse effect of drugs on constipation to be an
overestimated risk.
As far as we know the association between laxative use
and ability to communicate has not been reported before.
This is an interesting result indicating that patients having
problemsmaking themselves understood, and understanding
others, aremore likely to use laxatives.The bowel is a sensitive
organ that gives signals when the rectum is full. If the patient
has lost the ability to understand and to communicate their
bowel habits or need to defecate, it might lead to bowel
problems and a prescription for laxatives.
Being involved in activities from ≥1/3 to 2/3 of day-
time and antidementia medications were protective factors.
Antidementia medications have diarrhea as a known adverse
effect, which may lead to a lower risk for laxative use. The
covariate “time involved in activities” expresses the patient’s
involvement in activities either alone or in a group when the
patient is awake and not receiving treatment or care related
to activities of daily living. Hence, the result supports the
hypothesis that active living is protective against constipation
and the need for laxatives. It might also be that the most
active patients are able to manage their bowel independently
in terms of responding to the need to defecate. However, it is
worth mentioning that none of the other covariates involving
physical activity or ADL functioning were significantly asso-
ciated with laxative use in the adjusted analyses. Immobility
in general [23, 24] and loss of functional status have been
found to be a significant risk factor for laxative use in other
studies [8, 62].
Stroke was significantly associated with laxative use in
the univariable analyses, but not in the adjusted analyses.
Parkinson’s disease did not reach the significance level. Other
studies show varying results concerning the association
between Parkinson’s disease and use of laxatives, where Chen
et al. [62], did not find a significant association with either
diseases, but both Hosia-Randell et al. [24] and Harari et al.
[23] found an association betweenParkinson’s disease anduse
of laxatives. When investigating the relationship with stroke
and Parkinson’s disease it is possible that the nonsignificant
findings are due to the small number with these conditions
in the sample.
An important finding is the differences in the reported
prescriptions formicroenemas, small enemas, and oil enemas
in the patient record compared to what was reported as
used by the RNs. This indicates that RNs give patients these
drugs without prescription from the GP, which support
the hypotheses that in NHs RNs handle bowel problems
independently [61], including the administration of laxatives.
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4.3. Constipation and Laxative Use. When investigating and
comparing variance on theNHunit level and the patient level,
our results show that the significant variability in constipation
and laxative use among patients is largely explained by
difference in patients characteristics/health deficiencies, for
example, number of drugs, different medical diagnosis, or
ability to communicate. Although interRAI LTCF offers a
large number of variables, the results show a rather low
explained variability of 31.2% (constipation) and 36.9% (lax-
ative use). Hence, other variables should be considered. One
possible variable to discuss is the overall care routines in
the NH setting. Even though this study identified most of
the variance at the patient level, most of the patients are
dependent on care staff to compensate for the deficien-
cies that make them at risk for constipation and laxative
use.
Constipation and laxative use might be considered a
result of standardized routines where the patients have
not received an individualized assessment or treatment for
their bowel needs. This interpretation may be supported
by the positive association between constipation and urine
incontinence where care related to elimination in general is
determined by care routines and not the patients’ individual
needs, possibly leading to a worsening in ability to maintain
function. In spite of increased recognition of the importance
of the application of individualized treatment and care in
NHs, NHswith few nursing resources dedicated to the care of
older personsmight be based on standardization [63, 64] and
routine [65]. Several studies have identified care culture, with
standardized routines as a problem for individualized bowel
care [18, 31].
4.4. Strengths and Limitations. A major strength is the use
of interRAI LTCF with standardized and validated measures
for investigating prevalence and associations. A study inves-
tigating and comparing reliability in the different interRAI
instruments in 12 countries found the majority of the items
to exceed standard cut-offs for acceptable reliability [36].
However, the different scales have shown varying results for
validity and reliability [36, 45, 46, 66, 67], with the CHESS
scale and the DRS scale as the two with the most variable
results [67–69]. Another strength is that we have considered
the effect of clustering and tested whether a mixed effect
logistic regressionmodelmade a significantly better fit for the
data.
A limitation is that we did not use ROME III criteria
[70] when defining constipation among patients. InterRAI
LTCF only considers two aspects of constipation: no bowel
movements for three days, or problems with hard stools.
On the other hand, the ROME III definition of constipation
is problematic in this population because (1) many of the
patients are treated with laxatives and (2) patients are cog-
nitively impaired and might have a problem since ROME
III uses a combination of subjective symptoms to define
constipation which can be hard to verbalize for a cognitively
impaired person. Another limitation in our study is that it did
not include variables measuring the patients’ fiber or calorie
intake.
The use of a proxy, where the RNs filled in the interRAI
LTCF based on their knowledge about the patients’ health
condition, and not the patients themselves, might be con-
sidered a limitation. The reliability and validity of proxy
data is found to be high for tasks of daily living and health
conditions that are easily observed and relatively low for
conditions that are private and less likely to be reported
[71]. In the NH setting, most of the patients have cognitive
impairment, which make it difficult to answer questions or
fill in questionnaires.However, in order to get a representative
sample of the NHpopulation, we chose to design a study with
the use of proxy data.
Other limitations are that the relatively small sample
might have impeded the investigation of association of some
conditions, for example, Parkinson’s disease, stroke, and
multiple sclerosis, which were found significant in other
studies. This might threaten the external validity of the study
concerning the conditions in question. Only patients that
according to their patient record used laxatives or other
drugs regularly were defined as users in the analyses. Patients
with an “on demand” prescription were defined as nonusers.
Hence, patients defined as nonusers may have used laxatives
or other drugs and thereby influenced the results.
5. Conclusion
The prevalence of constipation was 24.1%, and was associated
with impaired balance, urinary incontinence, Parkinson’s
disease, and hypothyroidism. About 67% of the patients
used laxatives regularly. Laxative use was associated with
impaired ability to communicate and number of other drugs
used. Antidementia drugs and being involved in activities
were protective factors. Mixed-effects analyses of both the
constipation model and the laxative use model identified
variance between NH units as nonsignificant in explaining
the total variance. Hence, variance in constipation and
laxative use are mainly explained by different individual
patient characteristics/health deficiencies. NH patients are
dependent on care staff to compensate for health deficiencies.
NHswith few nursing resourcesmight perform care based on
standardization and routines.Hence, standardized caremight
be an important factor in order to explain constipation and
laxative use among patients.
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